<!DOCTYPE HTML>
<html>
  <head>
    <meta http-equiv="Content-type" content="text/html;" >
	<title>Modafinil</title>
	</head>
  <body onLoad="init();">
    <div data-role="page" data-theme="b">
  	<div data-role="header" data-theme="b" data-position="fixed">
    	<h1>Modafinil</h1> 
    	<a href="#" data-rel="back" data-icon="arrow-l" data-theme="b" data-direction="reverse" >Back</a>
	</div>
    <div data-role="content">
<h3>Brand name: Provigil</h3>
<hr>
					<h3>Adult Starting Dose (Max Per Day)</h3>	
					<ul>
						<li>Initial stimulant dose in the mTBI patient = 100mg QAM </li>
						<li>Increase in increments of 100mg using split daily doses</li> 
						<li>Max stimulant dose in the mTBI patient = 400mg per day</li>
					</ul>
<hr>
					<h3>Advantages</h3>	
					<ul>
						<li>Use as a stimulant for treating fatigue in mTBI patients</li>
					</ul> 
<hr>
					<h3>Disadvantages</h3>	
					<ul>
						<li>Adverse Events: headache and asthesia</li>
						<li>Reduce the dose to one-half that recommended in one with hepatic impairment</li>
					</ul>
<hr>
					<h3>Pregnancy Category</h3>	
					<ul>
							<li>Risk cannot be ruled out, but potential benefits may justify potential risk</li>	
					</ul>
<hr>
					<h3>Safety Margins</h3>	
					<ul>
						<li>Methylphenidate and Modafinil contraindicated within 14 days following MAOI therapy </li>
						<li>Contraindications with Methylphenidate are halogenated anesthetics; Do not administer on the day of surgery </li>
						<li>Avoid concurrent use with alcohol </li>
						<li>Avoid concurrent use of Methylphenidate with ephedra and yohimbe</li>
					</ul>



    </div><!-- end jqm content -->
   
    </div><!-- end jqm page -->
  </body>
</html>
